South America Doxorubicin Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drug Formulation (Lyophilized Powder and Doxorubicin Injection), Application (Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
The SAM doxorubicin market is expected to grow from US$ 65.06 million in 2022 to US$ 86.34 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2022 to 2028.
Both chemotherapy and targeted therapy significantly improve cancer patients' chances of survival and quality of life. These therapies may bring about the complete remission of a tumor. Owing to these benefits, the demand for chemotherapy has surged across the region. Advanced cancer treatments improve patient survival and increase long-term outpatient chemotherapy requirements. More exposure to chemotherapy results in a greater demand for doxorubicin drugs, thereby boosting the market growth across the region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM doxorubicin market. The SAM doxorubicin market is expected to grow at a good CAGR during the forecast period.
SAM Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
SAM Doxorubicin Market Segmentation
The SAM doxorubicin market is segmented based on drug formulation, application, distribution channel, and country. Based on drug formulation, the SAM doxorubicin market is bifurcated into lyophilized powder and doxorubicin injection. The lyophilized powder segment dominated the market in 2022. Based on application, the SAM doxorubicin market is segmented into breast cancer, kidney cancer, liver cancer, sarcoma, ovarian cancer, lung cancer, leukemia, multiple myeloma, and others. The breast cancer segment dominated the market in 2022. Based on distribution channel, the SAM doxorubicin market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the market in 2022. Based on country, the SAM doxorubicin market has been categorized into Brazil, Argentina, and rest of SAM. Our regional analysis states that Brazil dominated the market in 2022.
Accord Healthcare; Baxter International Inc.; Cipla Inc.; Dr. Reddy's Laboratories; Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.); Meiji Holdings Co., Ltd.; Novartis AG; Pfizer Inc.; Sun Pharmaceutical Industries Ltd; and Zydus Cadila are among the leading companies in the SAM doxorubicin market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Doxorubicin Market – By Drug Formulation
1.3.2 SAM Doxorubicin Market – By Application
1.3.3 SAM Doxorubicin Market – By Distribution Channel
1.3.4 SAM Doxorubicin Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Doxorubicin Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinion
5. SAM Doxorubicin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cancer
5.1.2 Increasing Preference for Chemotherapy
5.2 Market Restraints
5.2.1 Potential Side-effects Associated with Doxorubicin
5.3 Market Opportunities
5.3.1 Increasing Government Funding, Guidance, and Technical Assistance for Cancer Prevention
5.4 Future Trends
5.4.1 Increasing Approval of Generic Products
5.5 Impact Analysis
6. Doxorubicin Market– SAM Analysis
6.1 SAM Doxorubicin Market Revenue Forecast and Analysis
7. SAM Doxorubicin Market Analysis – By Drug Formulation
7.1 Overview
7.2 SAM Doxorubicin Market Share, By Drug Formulation 2022 & 2028 (%)
7.3 Lyophilized Powder
7.3.1 Overview
7.3.2 Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
7.4 Doxorubicin Injection
7.4.1 Overview
7.4.2 Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8. SAM Doxorubicin Market Analysis – By Application
8.1 Overview
8.2 SAM Doxorubicin Market Share, By Application 2022 & 2028 (%)
8.3 Breast Cancer
8.3.1 Overview
8.3.2 Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.4 Kidney Cancer
8.4.1 Overview
8.4.2 Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.5 Liver Cancer
8.5.1 Overview
8.5.2 Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.6 Sarcoma
8.6.1 Overview
8.6.2 Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.7 Ovarian Cancer
8.7.1 Overview
8.7.2 Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.8 Lung Cancer
8.8.1 Overview
8.8.2 Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.9 Leukemia
8.9.1 Overview
8.9.2 Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.10 Multiple Myeloma
8.10.1 Overview
8.10.2 Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9. SAM Doxorubicin Market Analysis – By Disribution Channel
9.1 Overview
9.2 SAM Doxorubicin Market Share, By Disribution Channel 2022 & 2028 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
10. SAM Doxorubicin Market Analysis – By Country
10.1 Overview
10.1.1 SAM: Doxorubicin Market, by Country, 2022 & 2028 (%)
10.1.1.1 Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.1.1.4 Brazil: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.5 Brazil: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.1.2 Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.1.2.4 Argentina: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.5 Argentina: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.1.3 Rest of South and Central America: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of SAM: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of SAM: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.1.3.4 Rest of SAM: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.5 Rest of SAM: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Accord Healthcare
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Cipla Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Dr. Reddy's Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Meiji Holdings Co., Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Novartis AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pfizer Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Sun Pharmaceutical Industries Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Baxter International Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Zydus Cadila
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM Doxorubicin Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. Brazil: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 5. Argentina Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 8. Rest of SAM: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 9. Rest of SAM: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. Rest of SAM Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 11. Organic Developments Done By Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM Doxorubicin Market Segmentation
Figure 2. SAM Doxorubicin Market Segmentation, By Country
Figure 3. SAM Doxorubicin Market Overview
Figure 4. SAM Doxorubicin Market, By Drug Formulation
Figure 5. SAM Doxorubicin Market, By Country
Figure 6. SAM: PEST Analysis
Figure 7. SAM Doxorubicin Market Impact Analysis Of Driver And Restraints
Figure 8. SAM Doxorubicin Market– Revenue Forecast and Analysis
Figure 9. SAM Doxorubicin Devices Market Share, By Drug Formulation 2022 & 2028 (%)
Figure 10. SAM Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 11. SAM Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 12. SAM Doxorubicin Devices Market Share, By Application 2022 & 2028 (%)
Figure 13. SAM Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 14. SAM Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 15. SAM Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 16. SAM Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 17. SAM Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 18. SAM Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 19. SAM Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 20. SAM Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 21. SAM Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 22. SAM Doxorubicin Devices Market Share, By Disribution Channel 2022 & 2028 (%)
Figure 23. SAM Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 24. SAM Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 25. SAM Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 26. SAM: Doxorubicin Market, By Key Country – Revenue (2022) (US$ Million)
Figure 27. SAM: Doxorubicin Market, by Country, 2022 & 2028 (%)
Figure 28. Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Rest of SAM: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
- Accord Healthcare
- Baxter International Inc.
- Cipla Inc.
- Dr. Reddy's Laboratories
- Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
- Meiji Holdings Co., Ltd.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Zydus Cadila
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM doxorubicin market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM doxorubicin market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the doxorubicin market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution